1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Migraine Disorder: new trials by email Literature Review of Migraine Disorder trials Research Report on Migraine Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine ALD403 (Eptinezumab) - Migraine Disorder | Phase 3 | Completed | Alder Biopharmaceuticals, Inc. | 128 | 2016-12-01 | 2020-04-21 |
Brain Diseases (1) · Central Nervous System Diseases (1) · Headache Disorders (1) · Headache Disorders, Primary (1) · Nervous System Diseases (1)
eptinezumab (1)
Alder Biopharmaceuticals, Inc. (1)
United States (1)